Market Cap 4.18M
Revenue (ttm) 0.00
Net Income (ttm) -8.21M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 234,828
Avg Vol 183,556
Day's Range N/A - N/A
Shares Out 2.52M
Stochastic %K 94%
Beta -1.59
Analysts Sell
Price Target $22.00

Company Profile

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a no...

Industry: Biotechnology
Sector: Healthcare
Phone: 619 400 1170
Address:
2223 Avenida de la Playa, Suite 208, La Jolla, United States
Raxothus
Raxothus Sep. 8 at 6:47 PM
EOD CONTINUATION FOLLOW-UP – 09/08/25 Tracking continuation watchlist from today based on intraday highs vs. close ✅ $ISPO – Closed 3.18, HOD 3.38 (+6.3%). Still over VWAP 3.13, valid continuation. ❌ $GRI – Closed 1.64, HOD 1.78 (+8.5%), now 1.54 under VWAP 1.61. Full fade, failed continuation. ✅ $LOOP – Closed 1.85, HOD 1.99 (+7.6%). Strong continuation, clean push over VWAP 1.91. ❌ $FBIO – Closed 3.64, HOD 3.90 (+7.1%), now 3.63 under VWAP 3.65. Failed continuation, rejected VWAP. ⚠️ $PYXS – Closed 1.91, HOD 2.00 (+4.7%). Weak follow-through, under VWAP 1.95, borderline continuation. Recap: 5 total → 2 winners, 1 neutral, 2 fails → 40% accuracy Leader: $LOOP (+7.6%) gave the strongest continuation move. #VWAP #SmallCaps #DayTrading #EODFollowUp #Continuation #SniperSetup #Accountability
0 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 8 at 6:21 PM
$GRI ....$AVO .... Avacados for the win duh.
0 · Reply
j123321
j123321 Sep. 8 at 6:13 PM
$GRI is Next $OCTO in the making.. $GRI expected topline data in next few days Don't miss your next ride to NORTH :)
1 · Reply
Limer_814
Limer_814 Sep. 8 at 5:59 PM
$GRI same
0 · Reply
Phyrodox
Phyrodox Sep. 8 at 5:41 PM
$GRI buying more on the dips
0 · Reply
nothximgood
nothximgood Sep. 8 at 4:01 PM
1 · Reply
faithTrades
faithTrades Sep. 8 at 3:46 PM
$GRI never fails… lol
0 · Reply
Wildblitz
Wildblitz Sep. 8 at 2:09 PM
$GRI Of course it drops
1 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 8 at 1:53 PM
$GRI why this does its thing... i bet .06 on $13 call on $OPEN that expires this Friday 🤣🤔
0 · Reply
Limer_814
Limer_814 Sep. 8 at 1:21 PM
$GRI So top line data 3rd quarter per Ceo , that means September !! Lets goo
1 · Reply
Latest News on GRI
GRI Bio Announces Closing of $5.0 Million Public Offering

Apr 2, 2025, 4:05 PM EDT - 5 months ago

GRI Bio Announces Closing of $5.0 Million Public Offering


GRI Bio Announces Pricing of $5.0 Million Public Offering

Apr 1, 2025, 11:15 AM EDT - 5 months ago

GRI Bio Announces Pricing of $5.0 Million Public Offering


Why Is Nano Cap GRI Bio Stock Skyrocketing On Tuesday?

Apr 1, 2025, 11:07 AM EDT - 5 months ago

Why Is Nano Cap GRI Bio Stock Skyrocketing On Tuesday?


GRI Bio Participates in a Virtual Investor CEO Connect Segment

Mar 18, 2025, 9:05 AM EDT - 6 months ago

GRI Bio Participates in a Virtual Investor CEO Connect Segment


GRI Bio Regains Compliance with Nasdaq's Minimum Bid Price Rule

Mar 11, 2025, 8:35 AM EDT - 6 months ago

GRI Bio Regains Compliance with Nasdaq's Minimum Bid Price Rule


GRI Bio Announces Reverse Stock Split

Feb 19, 2025, 4:05 PM EST - 7 months ago

GRI Bio Announces Reverse Stock Split


GRI Bio Announces Exercise of Warrants

Oct 21, 2024, 5:35 PM EDT - 11 months ago

GRI Bio Announces Exercise of Warrants


GRI Bio to Present at the 2024 European Respiratory Congress

Sep 4, 2024, 8:45 AM EDT - 1 year ago

GRI Bio to Present at the 2024 European Respiratory Congress


GRI Bio Regains Compliance with Nasdaq

Jul 8, 2024, 9:05 AM EDT - 1 year ago

GRI Bio Regains Compliance with Nasdaq


GRI Bio to Present at the 8th Annual IPF Summit

Jul 1, 2024, 8:45 AM EDT - 1 year ago

GRI Bio to Present at the 8th Annual IPF Summit


GRI Bio Announces Closing of $4.0 Million Public Offering

Jun 28, 2024, 4:05 PM EDT - 1 year ago

GRI Bio Announces Closing of $4.0 Million Public Offering


Raxothus
Raxothus Sep. 8 at 6:47 PM
EOD CONTINUATION FOLLOW-UP – 09/08/25 Tracking continuation watchlist from today based on intraday highs vs. close ✅ $ISPO – Closed 3.18, HOD 3.38 (+6.3%). Still over VWAP 3.13, valid continuation. ❌ $GRI – Closed 1.64, HOD 1.78 (+8.5%), now 1.54 under VWAP 1.61. Full fade, failed continuation. ✅ $LOOP – Closed 1.85, HOD 1.99 (+7.6%). Strong continuation, clean push over VWAP 1.91. ❌ $FBIO – Closed 3.64, HOD 3.90 (+7.1%), now 3.63 under VWAP 3.65. Failed continuation, rejected VWAP. ⚠️ $PYXS – Closed 1.91, HOD 2.00 (+4.7%). Weak follow-through, under VWAP 1.95, borderline continuation. Recap: 5 total → 2 winners, 1 neutral, 2 fails → 40% accuracy Leader: $LOOP (+7.6%) gave the strongest continuation move. #VWAP #SmallCaps #DayTrading #EODFollowUp #Continuation #SniperSetup #Accountability
0 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 8 at 6:21 PM
$GRI ....$AVO .... Avacados for the win duh.
0 · Reply
j123321
j123321 Sep. 8 at 6:13 PM
$GRI is Next $OCTO in the making.. $GRI expected topline data in next few days Don't miss your next ride to NORTH :)
1 · Reply
Limer_814
Limer_814 Sep. 8 at 5:59 PM
$GRI same
0 · Reply
Phyrodox
Phyrodox Sep. 8 at 5:41 PM
$GRI buying more on the dips
0 · Reply
nothximgood
nothximgood Sep. 8 at 4:01 PM
1 · Reply
faithTrades
faithTrades Sep. 8 at 3:46 PM
$GRI never fails… lol
0 · Reply
Wildblitz
Wildblitz Sep. 8 at 2:09 PM
$GRI Of course it drops
1 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 8 at 1:53 PM
$GRI why this does its thing... i bet .06 on $13 call on $OPEN that expires this Friday 🤣🤔
0 · Reply
Limer_814
Limer_814 Sep. 8 at 1:21 PM
$GRI So top line data 3rd quarter per Ceo , that means September !! Lets goo
1 · Reply
nothximgood
nothximgood Sep. 8 at 1:14 PM
$GRI let's go retail!
0 · Reply
faithTrades
faithTrades Sep. 8 at 11:34 AM
$GRI who’s ready for the ride? Hopefully it’s not another hat trick! lol
0 · Reply
Limer_814
Limer_814 Sep. 8 at 11:21 AM
0 · Reply
Peaceouty
Peaceouty Sep. 8 at 11:16 AM
$GRI If top line data show further evidence of disease reversal we will be looking at a 10 bagger right after data release. Keep in mind that there’s almost 12 million warrants that will generate approximately $22 million. This will provide significant cash runway.
0 · Reply
Limer_814
Limer_814 Sep. 8 at 11:06 AM
$GRI this chic is thin af.. me liking it
0 · Reply
Peaceouty
Peaceouty Sep. 8 at 10:31 AM
$GRI GRI-0621 is currently the only drug in clinical testing for IPF with biomarker evidence suggestive of actual reversal of fibrosis, not just slowing progression.
0 · Reply
Peaceouty
Peaceouty Sep. 8 at 10:25 AM
$GRI They say that interim data shows reversal. That’s huge, no other drug on the market does this. Competitors slow disease progression by 50%
0 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 8 at 9:43 AM
$GRI Looking like Billion $ iPf Data🤑🤑🤑🤑🤑
0 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 7 at 10:28 PM
$XBI $GRI bio Topline iPf trial results due soon. 3rd quarter 2025. We ALL KNOW HOW MUCH iPf data is worth🤑🤑🤑 $UTHR popped up 5 billion market cap on their iPf data. Gri $1.70 share 2.5 million share float Aprx. 4 million market cap
0 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 7 at 9:08 PM
$GRI The subject group may be small for the iPf trial. But a few years back $BBIO shot up almost BILLION in market cap for a 10 subject dwarfism study. Great results, Small share float could super boost this market cap for Gri
0 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 7 at 6:37 PM
$GRI 200million Market cap is aprx $85 a share. Note* $PLRX traded and carried a 900 MILLION $ Market cap while they in their iPf trial. Once they discontinued iPF trial their Market cap went to Aprx 100 million market cap. How much is ipf trial market cap worth?
0 · Reply
NolAsrtormZ
NolAsrtormZ Sep. 7 at 6:32 PM
$GRI Cash Register sounds $105--->$170
0 · Reply